-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Drug source analysis
Drug source analysisAlthough society invests a lot of resources in tumor research and product development every year, the treatment of advanced tumors is still not satisfactory.
Some people say that you are only talking about it, what's wrong with it if you listen to it and catch it early? There are several factors in this.
Therefore, the value of early screening is related to factors such as the proportion of malignant subtypes of specific tumors, the sensitivity of detection techniques, and the toxicity of standard therapies.
Therefore, it is unreliable to use screening for tumor-specific mortality reduction as the only measure.
Another thing that increases the value of early screening is that the entire industry needs to consider how to develop better early cancer drugs.
Sharpless is an important contemporary chemist.